首頁 › 神經膠質瘤 › 俄亥俄州 › Cincinnati
Cincinnati, OH 的 神經膠質瘤 臨床試驗
9 項針對 神經膠質瘤 的研究正在 Cincinnati(約 30 英里範圍內)及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本(英文)
正在為研究招募對象嗎?將此頁面置頂展示 — $99 / 30 天 →
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
招募中1/2 期
- Cincinnati Children's Hospital Medical Center, Cincinnati
ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
招募中2 期
- Cincinnati Children's Hospital, Cincinnati
Targeted Pediatric High-Grade Glioma Therapy
招募中觀察性研究
- Cincinnati Children's Hospital Medical Center, Cincinnati
Study of Olutasidenib and Temozolomide in HGG
招募中2 期
- Cincinnati Children's Hospital Medical Center, Cincinnati
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
招募中2 期
- Cincinnati Children's Hospital Medical Center, Cincinnati
Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
招募中1/2 期
- Cincinnati Children's Hospital Medical Center, Cincinnati
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
招募中早期第 1 期歡迎健康志工
- Cincinnati Children's Hospital Medical Center, Cincinnati
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
招募中2 期
- Cincinnati Children's Hospital Medical Center, Cincinnati
A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion
招募中早期第 1 期
- Cincinnati Children's Hospital Medical Center, Cincinnati
其他城市的 神經膠質瘤 試驗
- New York City, NY25 項研究
- Houston, TX23 項研究
- Boston, MA20 項研究
- Washington, DC19 項研究
- Philadelphia, PA16 項研究
- Columbus, OH15 項研究
- Miami, FL15 項研究
- San Francisco, CA14 項研究
- Chicago, IL13 項研究
- Durham, NC12 項研究
- Seattle, WA11 項研究
- Los Angeles, CA10 項研究
Cincinnati 的其他研究
- 非小細胞肺癌35 項研究
- 癌症(所有類型)27 項研究
- 乳癌25 項研究
- 心臟衰竭24 項研究
- 大腸直腸癌21 項研究
- 急性髓系白血病20 項研究
- 轉移性癌症20 項研究
- 卵巢癌19 項研究
- 肺癌19 項研究
- 肥胖症19 項研究
- 前列腺癌18 項研究
- 多發性骨髓瘤17 項研究
資料來源:ClinicalTrials.gov,擷取日期 2026年10月5日。各研究自行設定資格標準;由研究團隊決定參與者資格。